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Summary 
Mood states and immunity may be related. To investigate the immune 
status of patients with primary depressive illness, we compared in-vitro 
lymphocytic responses to three different mitogens in 26 drug-freede- 
pressed patients and 20 normal controls of comparable age and sex. We 
observed a generalized and marked decrease in the lymphocyte mitogenic 
activity among the depressive group. This defect in lymphocyte function 
may be indicative of an impairment in cell-mediated immunity in patients 
with primary depressive illness. 
For more than 2000 years, clinicians have observed that mood states may 
affect susceptibility to physical illness. In 200 A.D., the Greek scientist Galen 
noted that melancholic women developed breast cancer more frequently than 
sanguine women (1). Recent epidemiologic studies tend to support this conclu- 
sion (2). Depression may be associated with a variety of medical illnesses 
including cancer (3)) infection (4) and allergic disorders (5), conditions re- 
portedly linked to derangements in immune function. The immune status of 
patients with affective disorders, however, has not been systematically invest- 
igated. Preliminary studies suggest that psychosocial stressors such as 
bereavement (6) and sleep deprivation (7) may be accompanied by an impairment 
in cell-mediated immunity. To address this issue in affective disorders, we 
studied in-vitro lymphocytic response to mitogen stimulation in patients with 
primary depressive illness and normal controls. We observed a generalized and 
marked reduction in the mitogenic activity among the depressive group. 
Subjects 
Two groups of subjects were studied: depressed patients (n=26) and 
normal controls (n=20). All patients have been evaluated at the Clinical Studies 
Unit, a research unit of the Department of Psychiatry at the University of 
Michigan Medical Center with special interest in affective disorders. The mean 
age of the depressed group was 41.69 5 14.44 (range:20-68) years. Eight 
patients were male, 18 female. All patients met the Research Diagnostic Criteria 
(RDC) (8) for major depressive disorder, primary subtype. Patients had a 
mean score of 16.26 ? 6.47 on the 17-item Hamilton Depression Rating Scale 
(HDRS) (9). The normal control group was composed of healthy euthymic 
volunteers. Their mean age was 36.60 2 14.90 (range:21-66) years. Eight 
*Current Address : Department of Psychiatry 
University of Iowa College of Medicine 
500 Newton Road, Iowa City, Iowa 52242 
0024-3205183 $3.00 + .OO 
Copyright (c) 1983 Pernamon Press Ltd. 
242 Lymphocyte Function in Depression Vol. 33, No. 3, 1983 
subjects were male, 12 female. All patients and controls were free of medical 
illnesses known to interfere with the reactivity of lymphocytes in culture and 
were drug-free for at least two weeks prior to the immune testing. Informed 
consent was obtained from all participating subjects. 
Methods 
Twenty milliliters of venous blood were collected from each subject at 8:00 
a.m., anticoagulated with 100 units of preservative-free sodium-heparin and 
centrifuged over Ficoll-Hypaque at 400 x g. for 40 minutes. A lymphocyte-rich 
fraction was extracted and washed with phosphate buffered saline (pH:7.4). 
Lymphocytes were resuspended in a mixture of RPMI-1640 tissue culture medium 
containing 20% autologous plasma and 100 units/ml penicillin G and 100 mg/ml 
streptomycin. 
plates. 
Triplicate lymphocyte5 cultures were established in microtiter 
To each well were added 10 small lymphocytes (without correction for 
monocyte contamination) and one of the following mitogens : Phytohemagglutinin- 
P (PHA) (Difco Inc., Detroit, Michigan) in doses of 3.125, 6.25, 12.5, 25 or 
50 pg/ml; Concanavalin A (Con A) (Sigma Chemicals, St. Louis, Missouri), 
10 pglml; or Pokeweed Mitogen (PWM) (Gibco, Grand Island, New York), 1: 10 
dilution. Lymphocytes from all subjects were also cultured without mitogen to 
determine background transformations. 
All cultures were incubated at 37OC in a 5% CO2 humidified atmosphere. 
After 96 hours of incubation, 1 !_Ci of tritiated thymldine (specific activity, 20 
Ci/mmole) was added to each well and incubation was continued. Six hours 
later, the cultures were harvested onto Whatman glassfiber filter paper with a 
multiple-sample precipitator. Filter papers were washed 8-10 times with 0.85% 
NaCl and air-dried. Samples were then immersed in toluene and the radioactiv- 
ity measured with a liquid scintillation counter. 
Calculations and Statistical Analysis 
The arithmetic means of the triplicate samples were calculated and ex- 
pressed as scintillation counts per minute (cpm). Mitogen response was then 
recorded as the difference, in cpm, between stimulated and background (un- 
stimulated) counts. The data was then statistically analyzed with one-way 
analysis of variance (ANOVA) for intergroup comparisons. For PHA, since a 
dose-response curve was available, we compared the areas under the curves for 
the two groups. For Con A and PWM, comparisons were made for the specific 
concentrations used. 
Results 
Figure 1 shows the PHA dose-response curves for the depressed and 
cant rol groups . There was a reduction in lymphocyte mitogenic activity among 
the depressed group at all concentrations of PHA used. The area under the 
curve for the depressed group was 1289158 ? 104337 units (cpm x ~glml), 
compared to 1757939 2 118963 units for the control group. This difference was 
highly significant [F(1,44)=8.76; p=.OO49]. Since the largest difference in 
lymphocyte responses to PHA occurred at the concentration of 25 ug/ml, this 
concentration was used for further intergroup comparisons of recorded test 
values. Table I summarizes the results. Lymphocyte responses among the 
depressed group were markedly reduced with all three mitogens used. The 
results were statistically significant for PHA [F(1,44)=11.21; p=.OO17], Con A 
[F(1,44)=10.43; p=.OO23] and PWM [F(1,44)=17.30; p=.OOOl]. 
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FIG. 1 
PHA dose-response curves of peripheral blood lymphocytes from depressed 
paynts and normal controls. Values represent cpm (mean + SEMI, indicative 
of H-Thymidine incorporation into lymphocytes. 
PHA = Phytohemagglutinin-P; cpm = scintillation counts per minute 
*p < 0.005, areas under the curve, ANOVA. 
TABLE I 
In-Vitro Lymphocytic Responses to Mitogen Stimulation 
in Depressed Patients and Normal Controls 
Mitogen 
Tested* 
Depressed Patients Normal Controls F Values Probability Values 
(n = 26) (n = 20) (1,441 (two-tailed) 
25 uglml 27,904+2,659 41,410+3,032 11.21 .0017 
CON A 
10 uglml 29,462+3,768 47,938+4,296 10.43 .0023 
PWM 
1:lO 26,531+3,463 48,370+3,948 17.30 .OOOl 
* 
PHA, Phytohemagglutinin-P; CON A, Concanavalin A; PWM, Pokeweed Mitogen. 
The data are expressed as scintillation counts per minute (arithmetic means ? 
SEMI. 
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We then examined the relation between severity of depression and lympho- 
cyte transformations in the depressive group. Because the largest differences 
in lymphocyte responsiveness between the depressed and control groups were 
observed with PWM, responses to this mitogen were used to study the effects of 
depression severity. There was a weak negative correlation (r=-0.15; N.S. 1 
between lymphocyte responses to PWM and HDRS scores in the depressive group 
(Figure 2). 
We further divided the depressed patients, on the basis of their HDRS 
scores, in three subgroups: patients with a mild ‘depression (HDRS < 121, 
patients with a moderate depression (HDRS=12-20) and patients with severe 
depression (HDRS > 20). Figure 3 graphically illustrates the results. All 
three subgroups of depressed patients had significantly lower lymphocyte 
responses to PWM than the control group (p < -05, ANOVA). There was a 
trend, among depressed patients, for the lymphocyte stimulation counts to 
decrease with increasing seirerity of depression. The differences between the 
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FIG. 2 
Scatter Plot showing relationship between lymphocyte responses to PWM and 
HDRS scores in depressed patients. 
PWM = Pokeweed Mitogen 
HDRS = Hamilton Depression Rating Scale 
cpm = counts per minute 
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Lymphocyte Response to PWRl in depressed patients and normal controls. 
data are expressed in cpm (arithmetic means ? SEMI. 
PWM = Pokeweed Elitogen. 
Comparisons are made between the normal control group and each of the 
depressive subgroups. 
*p < 0.05 
** p < 0.01 
***p = 0.001 
Discussion 
A number of factors known to interfere with in-vitro lymphocytic responses 
to mitogen stimulation (10) should be considered in interpreting our results. 
Most relevant are nutritional factors (111, medical illness and drugs (101, 
diurnal variation (12) and age (13). Our patients were not undernourished 
(mean weight: 67.46 kgs) and all subjects with serious medical illnesses were 
excluded. All subjects were drug-free for at least two weeks prior to immune 
testing and patients who were receiving medications prior to this drug-free 
wash-out period did not differ significantly from those who were unmedicated. 
All blood samples were drawn at the same time of the day to control for possible 
diurnal variation, and all assays were performed the same day the blood was 
drawn. Age was slightly higher among the depressed group, but the difference 
was not statistically significant (t=l. 145; p=.25; N .S. 1. The female-to-male 
ratio mildly favored the depressed group, but again the sex differences were 
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not statistically significant (Fisher’s exact p=. 1985; N. S. > . Furthermore, in 
separate ANOVA and ANCOVA models (14) with age and sex as additional 
sources of variations between the groups, the basic differences in mitogenic 
activity between the depressed and control groups remained essentially un- 
changed (p < .Ol> for all three mitogens used. - 
Lymphocyte response to mitogen stimulation is a direct measure of in-vitro 
lymphocyte functional activity and a correlate of cell-mediated immunity.= 
and Con A stimulate mostly T-lymphocytes, the mediators of cellular immunity of 
the delayed type, while PWM stimulates primarily B-lymphocytes, the cells that 
mediate the production of immunoglobulins. Both T-lymphocytes and B-lympho- 
cytes are active in protecting the organism against infection. Moreover, T- 
lymphocytes mediate graft rejection and are also theorized to provide immune 
surveillance against cancer, whereas B-lymphocytes play a major role in auto- 
immune diseases. 
A decrease in in-vitro lymphocyte functional activity may be indicative of 
an impairment in ccl-ted immunity. The significant reductions in the 
mitogenic responses to PHA, Con A and PWM in the depressed group suggest a 
generalized impairment of immune function in patients with this illness. Whether 
such an impairment contributes to the increased vulnerability of depressed 
patients to medical illnesses such as infection (15) and neoplasm (16) remains to 
be determined. Depressed patients are also known to be hypersecretors of 
cortisol (17). The effect of hypercortisolemia on the overall immune status of 
depressed patients is currently under investigation. Furthermore, there have 
recently been reports of a possible association between HLA and depression 
(18). Our findings of impaired immunity in depressive illness thus suggest a 
complex interface between genetic, immune, neuroendocrine and behavioral 
regulation, and open the way for future research into the “psychoneuroim- 
munology” of depressive disorders. 
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